BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26630530)

  • 1. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.
    Chang CH; Sakaguchi M; Dolin P
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1196-1203. PubMed ID: 27221971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.
    Lee KT; Yeh YH; Chang SH; See LC; Lee CH; Wu LS; Liu JR; Kuo CT; Wen MS
    Medicine (Baltimore); 2017 Jul; 96(28):e7507. PubMed ID: 28700501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies.
    Wang T; Chai B; Chen WY; Holmes MD; Erdrich J; Hu FB; Rosner BA; Tamimi RM; Willett WC; Kang JH; Eliassen AH
    Int J Cancer; 2024 Jul; 155(2):211-225. PubMed ID: 38520039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Use in Type 2 Diabetics and Delirium After Noncardiac Surgery: A Retrospective Cohort Analysis.
    Paredes S; Harb A; Rössler J; Nikoo MZ; Ruetzler K; Turan A; Pu X; Sessler DI
    Anesth Analg; 2024 Jun; 138(6):1304-1312. PubMed ID: 38517762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and the risks of cellulitis, foot infections, and amputation in patients with type 2 diabetes.
    Yeh YK; Yen FS; Wei JC; Hu KC; Yu TS; Hsu CC; Hwu CM
    J Chin Med Assoc; 2024 Apr; 87(4):384-392. PubMed ID: 38417132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis.
    Hou YC; Hu Q; Huang J; Fang JY; Xiong H
    Oncotarget; 2017 Jan; 8(5):8843-8853. PubMed ID: 27903961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction.
    Sun M; Chen WM; Wu SY; Zhang J
    Brain; 2024 Apr; 147(4):1474-1482. PubMed ID: 37878862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acarbose treatment and the risk of cardiovascular disease in type 2 diabetic patients: a nationwide seven-year follow-up study.
    Chen JM; Chang CW; Lin YC; Horng JT; Sheu WH
    J Diabetes Res; 2014; 2014():812628. PubMed ID: 25197673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use as a moderator on the association between metformin and breast cancer risk in women with type 2 diabetes mellitus.
    Zhang F; de Bock GH; Landman GW; Zhang Q; Sidorenkov G
    Cancer Metab; 2024 Apr; 12(1):12. PubMed ID: 38610045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on "Risk analysis of metformin use in prostate cancer: a national population-based study".
    Lai SW; Hwang BF; Liu CS; Liao KF
    Aging Male; 2024 Dec; 27(1):2340087. PubMed ID: 38590117
    [No Abstract]   [Full Text] [Related]  

  • 12. Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis.
    Nayan M; Finelli A; Jewett MA; Juurlink DN; Austin PC; Kulkarni GS; Hamilton RJ
    Clin Genitourin Cancer; 2017 Apr; 15(2):300-305. PubMed ID: 27424258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and rhinitis in a nationwide study of children and adults in the United States.
    Han YY; Forno E; Gogna M; Celedón JC
    J Allergy Clin Immunol; 2016 May; 137(5):1460-5. PubMed ID: 26883461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Platelet-to-Lymphocyte Ratio on Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction.
    Sun XP; Li J; Zhu WW; Li DB; Chen H; Li HW; Chen WM; Hua Q
    Angiology; 2017 Apr; 68(4):346-353. PubMed ID: 27381032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Metformin Use With Cancer-Specific Mortality in Hepatocellular Carcinoma After Curative Resection: A Nationwide Population-Based Study.
    Seo YS; Kim YJ; Kim MS; Suh KS; Kim SB; Han CJ; Kim YJ; Jang WI; Kang SH; Tchoe HJ; Park CM; Jo AJ; Kim HJ; Choi JA; Choi HJ; Polak MN; Ko MJ
    Medicine (Baltimore); 2016 Apr; 95(17):e3527. PubMed ID: 27124061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
    Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
    Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus.
    Chong RW; Vasudevan V; Zuber J; Solomon SS
    Am J Med Sci; 2016 Apr; 351(4):416-9. PubMed ID: 27079349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use and survival from lung cancer: A population-based cohort study.
    Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
    Lung Cancer; 2016 Apr; 94():35-9. PubMed ID: 26973204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide.
    Saag KG; Agnusdei D; Hans D; Kohlmeier LA; Krohn KD; Leib ES; MacLaughlin EJ; Alam J; Simonelli C; Taylor KA; Marcus R
    Arthritis Rheumatol; 2016 Sep; 68(9):2122-8. PubMed ID: 27111239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin may reduce oral cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Jan; 7(2):2000-8. PubMed ID: 26683519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.